Forbes March 31, 2025
Abigail Dubiniecki

The genetic data that 15 million people entrusted to 23andMe to learn more about their ancestry and health could soon be sold to the highest bidder as “distressed assets” in 23andMe bankruptcy proceedings. According to 23andMe’s March 26 open letter, the Chapter 11 filing doesn’t change how 23andMe stores and protects customer data during this process. The company will continue to operate, and customers can access and change their accounts as normal during this time.

But many customers are distressed about what will...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Privacy / Security
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article